Clinical Trials
3 trialsNCT02399137 2018-09-18
CARRIE
Merrimack Pharmaceuticals
Phase 2 Completed
NCT02538627 2017-09-05
Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib
Merrimack Pharmaceuticals
Phase 1 Terminated
NCT01733004 2016-08-04
A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
Merrimack Pharmaceuticals
Phase 1 Completed